AMAG Pharmaceuticals
1100 Winter Street
Waltham
Massachusetts
02451
United States
Tel: 617-498–3300
Fax: 617-499-3361
Website: http://www.amagpharma.com/
Email: contactus@amagpharma.com
About AMAG Pharmaceuticals
Founded in 1981, AMAG Pharmaceuticals is committed to improving the health outcomes of patients through the development and commercialization of specialty pharmaceutical products.
AMAG currently markets a therapeutic intravenous iron compound for the treatment of iron deficiency anemia in adult patients with chronic kidney disease (CKD) and an oral rinse for the management of oral mucositis in the United States. To learn more about our products, click here. Along with driving organic growth of its lead product, AMAG intends to expand its portfolio with additional commercial-stage specialty pharmaceuticals. The company is seeking complementary products that leverage the company's commercial footprint and focus on hematology and oncology centers and hospital infusion centers.
Our iron oxide particles are composed of bioavailable iron that is easily absorbed by the body and incorporated into the body's iron stores. As a result, products using our core technology are well suited for use in intravenous iron replacement therapy.
374 articles about AMAG Pharmaceuticals
-
AMAG Pharmaceuticals, Inc. to Present at the Eighth Annual Needham Life Sciences Conference
6/4/2009
-
AMAG Pharmaceuticals, Inc. to Present at Deutsche Bank 34th Annual Healthcare Conference
5/14/2009
-
AMAG Pharmaceuticals, Inc. Announces New PDUFA Date for Feraheme (ferumoxytol injection)
5/13/2009
-
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended March 31, 2009
5/1/2009
-
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Quarter Ended March 31, 2009
4/24/2009
-
AMAG Pharmaceuticals, Inc.'s CEO Brian J.G. Pereira, MD, Receives 2009 David M. Hume Award
3/27/2009
-
AMAG Pharmaceuticals, Inc. to Present at Citi’s 4th Annual Biotech Day
3/27/2009
-
AMAG Pharmaceuticals, Inc. to Present at the Cowen and Company 29th Annual Healthcare Conference
3/13/2009
-
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter and Year Ended December 31, 2008
2/27/2009
-
AMAG Pharmaceuticals, Inc. to Host Conference Call to Discuss Financial Results for the Quarter and Year Ended December 31, 2008
2/10/2009
-
AMAG Pharmaceuticals, Inc. Announces Appointment of Robert J. Perez to Board of Directors
1/27/2009
-
AMAG Pharmaceuticals, Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference
1/8/2009
-
AMAG Pharmaceuticals, Inc. Receives Complete Response Letter from the FDA for Ferumoxytol, Delays Approval
12/23/2008
-
AMAG Pharmaceuticals, Inc. Says FDA Accepts Anemia Drug Response; Shares Soar in Pre-Market Trade; FDA Establishes December 30, 2008 PDUFA Action Date
11/13/2008
-
AMAG Pharmaceuticals, Inc. to Present at the Deutsche Bank 2008 Biotech Boston Confab
11/5/2008
-
AMAG Pharmaceuticals, Inc. Reports Financial Results for the Quarter Ended September 30, 2008
11/4/2008
-
AMAG Pharmaceuticals, Inc. to Host Conference Call on November 3, 2008 to Discuss Financial Results for the Quarter Ended September 30, 2008
10/29/2008
-
AMAG Pharmaceuticals, Inc. Gets FDA Request for More Data on Anemia Drug
10/20/2008
-
AMAG Pharmaceuticals, Inc. to Present at Two Upcoming Investor Conferences
8/27/2008
-
AMAG Pharmaceuticals, Inc. Imaging Agent Gets FDA Fast-Track Designation
8/22/2008